PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Credit Suisse Healthcare Conference in Phoenix, AZ. Emma Reeve, Corporate Vice President and Interim Chief Financial Officer, will be making a presentation on PAREXEL and discuss business developments at 10:00 a.m. MT on Monday, November 7, 2016.

A live webcast of the presentation (audio with slides) will be available through the “Investors” section of PAREXEL’s website at www.PAREXEL.com in the Upcoming Events portion of the main page, and a replay will be available for 90 days.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 84 locations in 51 countries around the world, and had approximately 18,600 employees in the fourth quarter. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL and PAREXEL Informatics are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates.